首页 | 本学科首页   官方微博 | 高级检索  
   检索      

sLea/x与肿瘤血源性转移研究进展
引用本文:彭云丽,李静,耿美玉.sLea/x与肿瘤血源性转移研究进展[J].中国生物工程杂志,2007,27(6):92-95.
作者姓名:彭云丽  李静  耿美玉
作者单位:中国海洋大学 中国海洋大学
基金项目:国家重点基础研究发展计划(973计划)
摘    要:肿瘤细胞表面sLea/x的表达水平与组织病理学参数正相关,且是转移性疾病的一个很重要的预后指标1]。ssLea/x与其配体E-选择素的结合启动了肿瘤血源性转移的发生。sLea/x与其配体的相互作用需要一定的活性构象,而基于模拟sLea/x的生物活性结构而设计的一类小分子化合物,可以有效地抑制sLea/x与其配体的结合,从而发挥抗肿瘤作用。本论文对近年来sLea/x与肿瘤血源性转移关系的研究及相关药物开发进行了综述。

关 键 词:sLea/x  肿瘤  血源性转移  活性构象
收稿时间:2006-12-04
修稿时间:2006-12-042007-01-26

Studies on sLea/x and hematogenous metastasis of cancer
PENG Yun-li,LI Jing,GENG Mei-yu.Studies on sLea/x and hematogenous metastasis of cancer[J].China Biotechnology,2007,27(6):92-95.
Authors:PENG Yun-li  LI Jing  GENG Mei-yu
Institution:School of Medicine and Pharmacy,Ocean University of China, Qingdao 266003,China
Abstract:The expression of sLea/x which correlates with conventional histopathologic parameters serves as a useful indicator for the prognosis of metastatic disease. The bindings between sLea/x and their common ligand E-selectin initiate hematogenous metastasis of cancer. Certain bioactive conformation is crucial for the interaction between sLea/x and their ligands. Thus, a new class of compounds that mimic the structures of sLea/x can potently inhibit not only their functional bindings to selectins, but also the metastasis of cancer. This review is mainly on the sLea/x molecular structure,biosynthesis,distribution, especially the relationship between sLea/x and hematogenous metastasis of cancer and the design of drugs that mimic the structures of sLea/x.
Keywords:sLe~(a/x) Cancer Hematogenous metastasis Bioactive conformation
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国生物工程杂志》浏览原始摘要信息
点击此处可从《中国生物工程杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号